New Delhi [India], December 27 (ANI/Mediawire): Chronic Obstructive Pulmonary Disease, also known as COPD, is a progressive lung disease that compromises the lung's ability to function, thus making it harder for a person to breathe and hampering their health and productivity. The conditio
Researchers have now discovered that a receptor involved in our sensation of touch and warmth is present in our colon, opening up a potential therapeutic target for the management of chronic pain brought on by gastrointestinal conditions like irritable bowel syndrome.
New Delhi [India], December 23 (ANI/Mediawire): Getting stronger or going faster takes time. Sometimes we don't realize that we are putting excessive pressure on a particular body part then it can naturally withstand. The human body is extraordinarily susceptible to injury and breakdown,
While cluster headache is more common in men than in women, a new study suggests that the disorder may be more severe for women. The study is published in the December 21, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.
Despite the fact that 80 percent of mothers nurse their newborns, the Centers for Disease Control and Prevention reports that only 25 percent of women exclusively breastfeed their infants for the six months recommended by the United States Dietary Guidelines. Researchers found that social is
'Shazam' star Jack Dylan Grazer is the latest addition to the star cast of 'The Spiderwick Chronicles' TV series adaptation in the works at Disney Plus.
In animal models, researchers revealed how water enriched with hydrogen molecules (H2) reduces the symptoms of neuropathic pain and its associated emotional disorders.
According to research, patients taking efgartigimod, a medication being tested for use in the treatment of chronic primary immune thrombocytopenia (ITP), showed a significantly greater improvement in platelet counts, which are necessary for clotting and stopping bleeding, compared to those t
According to a new, phase 2 clinical trial led by Dana-Farber Cancer Institute doctors, a three-medicine combination that drove chronic lymphocytic leukaemia (CLL) patients into profound remissions in a clinical study is very beneficial in patients with high-risk variants of the disease.
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results